Sort
4,870 grants matching “glp 1”
Dissecting mechanisms by which GI surgery delays diabetes onset in UCD-T2DM rats
$334,950Peter J Havel · University Of California At Davis · R01 · FY2014 · DK
Mid Atlantic Heart Failure Network
$334,850Kenneth Ber Margulies · University Of Pennsylvania · U10 · FY2016 · HL
Foldamers: Novel Ligands for Diverse Protein Surfaces
$334,786Alanna Schepartz · Yale University · R01 · FY2012 · GM
The role of GLP-1 in normal and abnormal glucose tolerance
$334,680David A. D'alessio · University Of Cincinnati · R01 · FY2011 · DK
The role of GLP-1 in normal and abnormal glucose tolerance
$334,680David A. D'alessio · University Of Cincinnati · R01 · FY2012 · DK
Targeting Estrogen Receptors to Protect Functional Beta-cell Mass in Diabetes
$334,443Franck Mauvais-Jarvis · Tulane University Of Louisiana · R01 · FY2013 · DK
Glucagon Mediated Potentiation of Insulin Sensitivity in Glucose Metabolism
$334,125Kirk Michael Habegger · University Of Alabama At Birmingham · R01 · FY2019 · DK
Glucagon Mediated Potentiation of Insulin Sensitivity in Glucose Metabolism
$334,125Kirk Michael Habegger · University Of Alabama At Birmingham · R01 · FY2021 · DK
Glucagon Mediated Potentiation of Insulin Sensitivity in Glucose Metabolism
$334,125Kirk Michael Habegger · University Of Alabama At Birmingham · R01 · FY2017 · DK
Glucagon Mediated Potentiation of Insulin Sensitivity in Glucose Metabolism
$334,125Kirk Michael Habegger · University Of Alabama At Birmingham · R01 · FY2020 · DK
Glycoengineering of Therapeutic Peptides for Improved Treatment of Human Diseases
$334,092Tarek Sammakia · University Of Colorado · R01 · FY2019 · EB
Neurohumoral Regulation in Diabetic Enteropathy
$333,760Adil E. Bharucha · Mayo Clinic Rochester · P01 · FY2008 · DK
Glycoengineering of Therapeutic Peptides for Improved Treatment of Human Diseases
$333,643Tarek Sammakia · University Of Colorado · R01 · FY2020 · EB
MLL3/4-complexes in nuclear receptor-mediated metabolism
$333,601Jae W Lee · Oregon Health & Science University · R01 · FY2014 · DK
MLL3/4-complexes in nuclear receptor-mediated metabolism
$333,601Jae W Lee · Oregon Health & Science University · R01 · FY2016 · DK
MLL3/4-complexes in nuclear receptor-mediated metabolism
$333,601Jae W Lee · Oregon Health & Science University · R01 · FY2013 · DK
MLL3/4-complexes in nuclear receptor-mediated metabolism
$333,601Jae W Lee · Oregon Health & Science University · R01 · FY2015 · DK
Catalytic antioxidant for toxic inhaled chemicals
$333,525Carl W White · University Of Colorado Denver · U54 · FY2013 · ES
Glycoengineering of Therapeutic Peptides for Improved Treatment of Human Diseases
$333,520Tarek Sammakia · University Of Colorado · R01 · FY2021 · EB
Parallel-group randomized controlled trial of Pioglitazone versus empagliflozin for T3cDM: The PEP-DM Trial
$333,445Yogish C. Kudva · Mayo Clinic Rochester · R01 · FY2024 · DK
CORE E: RNA Manufacturing Core
$333,348John P Cooke · Albert Einstein College Of Medicine · U19 · FY2024 · AI
Appetite Hormones in Binge Eating Disorder
$333,330Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2007 · DK
Protease Operated Depot for Delivery of GLP-1
$332,609Ashutosh Chilkoti · Duke University · R01 · FY2014 · DK
Protease Operated Depot for Delivery of GLP-1
$332,609Ashutosh Chilkoti · Duke University · R01 · FY2012 · DK
Protease Operated Depot for Delivery of GLP-1
$332,609Ashutosh Chilkoti · Duke University · R01 · FY2015 · DK